GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

relatlimab   Click here for help

GtoPdb Ligand ID: 9536

Synonyms: BMS-986016 | BMS986016 | ONO-4482 | Opdualag® (nivolumab + relatlimab-rmbw) | relatlimab-rmbw
Approved drug Immunopharmacology Ligand
relatlimab is an approved drug (EMA & FDA (2022))
Compound class: Antibody
Comment: Relatlimab (BMS-986016) is an anti-LAG3 monoclonal antibody that was developed for utility in cancer immunotherapy.
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes. EU EMA (2022)  |  US FDA (2022)
International Nonproprietary Names Click here for help
INN number INN
10735 relatlimab
Synonyms Click here for help
BMS-986016 | BMS986016 | ONO-4482 | Opdualag® (nivolumab + relatlimab-rmbw) | relatlimab-rmbw
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 781
Other databases
GtoPdb PubChem SID 336446922
Search PubMed clinical trials relatlimab
Search PubMed titles relatlimab
Search PubMed titles/abstracts relatlimab